1. Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer;Negendank;Anticancer Research,1996
2. Measurements of human breast cancer using magnetic resonance spectroscopy;Leach;NMR in Biomed,1998
3. Broadband proton decoupling in human 31P NMR spectroscopy;Luyten;NMR in Biomed,1989
4. UO1 CA62557-02 (“31P MRS of Human Cancer”). Participating institutes (principal investigators) of the Co-operative Group for Magnetic Resonance Applications to Cancer (CoGMAC) are: Fox Chase Cancer Center, Philadelphia, PA (T.R. Brown; coordinating center), Duke University, Durham, NC (H.C. Charles), Memorial Sloane Kettering Hospital, New York, NY (J. Koutcher), Royal Marsden Hospital, Sutton, Surrey, UK (M.O. Leach), St. Georges Hospital, Tooting, London, UK (J. Griffiths), University Medical Center Nijmegen, Nijmegen, The Netherlands (A. Heerschap), University of Pennsylvania, Philadelphia, PA (J. Glickson), University of California at San Francisco, San Francisco, CA (S. Nelson), Wayne State University, Detroit, MI (J. Evelhoch).
5. SAR and tissue heating with clinical 31P MRS protocol using surface coils, adiabatic pulses and proton-decoupling;Schwarz;Magn Reson Med,2000